|
+8
|
Biopharma ER?
|
6h |
|
+15
|
Built a desktop valuation app (DCF / DDM / reverse DCF) so I'd stop rebuilding Excel models for every pitch — would value some ER feedback
|
6h |
|
+38
|
Are any ER juniors actually happy?
|
12h |
|
+7
|
Why hire an equity analyst if AI can write the reports
|
1d |
|
0
|
MLP Equities Analyst Program Update
|
2d |
|
+6
|
Advice for a new associate?
|
2d |
|
+114
|
Calling All Former ER: Where Did You Go?
|
2d |
|
+18
|
Former Pharma scientist with sell-side biotech ER experience — interview processes keep stalling, what am I missing
|
4d |
|
0
|
I truly don’t know what to do
|
6d |
|
|
|
+12
|
Started ER Internship, Reconsidering: Exit Opps?
|
6d |
|
0
|
Insurance investing conferences?
|
1w |
|
+32
|
Does anyone else find it very difficult to take vacations in ER?
|
1w |
|
+10
|
PayPal (PYPL): Why Is the Market Valuing PayPal Like a Low-Growth Company Despite Strong Free Cash Flow?
|
1w |
|
0
|
Resources to Find Info on Modeling a Biotech Company
|
1w |
|
+13
|
ER--Unusually long reference checks post-superday
|
1w |
|
+18
|
ER - Intern and Full Time QBank Technical Questions
|
1w |
|
0
|
Rising Senior in ER feeling lost/FT advice
|
1w |
|
+16
|
Intel (INTC): My Bull Case Still Doesn't Justify the Current Stock Price
|
1w |
|
0
|
JPM Equity Research SA27
|
1w |
|
+11
|
Thoughts on boutique ER firm opportunity and options afterwards
|
1w |
|
0
|
JPM Equity Research SA27?
|
1w |
|
+9
|
Rising Sophomore clueless about recruiting timeline
|
2w |
|
+7
|
Irenic Latest Views?
|
2w |
|
+14
|
Rising junior at semi-target, fumbled sophomore recruiting — how cooked am I really?
|
2w |
|
|
|
+9
|
Is equity research dead? If not, what aspects are still viable?
|
3w |
|
+40
|
Lowest Comp You'd Take For Lead Coverage
|
3w |
|
+8
|
What is the best path for me as MBA student to HF
|
1mo |
|
+9
|
CC student, help choose schools
|
1mo |
|
+16
|
DB ER?
|
1mo |
|
+18
|
ER Pulse Check... How We Doing?
|
1mo |
|
+17
|
Equity Research Today: What skills are actually most valuable for entry-level analysts?
|
1mo |
|
+20
|
Article: UBS: The Fragile Facade of a Post-Merger Powerhouse
|
1mo |
|
+66
|
Best B-school for Equity Research
|
1mo |
|
0
|
Do these basically kills the need of an Sell Side associate?
|
1mo |
|
+6
|
GS Off-Cycle GIR
|
1mo |
|
+37
|
MD hates me, what do I do?
|
1mo |
|
+10
|
Automating Equity Research Workflows — From 2–3 Hours to ~20 Minutes
|
1mo |
|
+12
|
Bored on the buyside
|
1mo |
|
+3
|
Power & utilities primer / initiation?
|
1mo |
|
+15
|
ER Case Study guidance
|
1mo |
|
+9
|
Notes from JBL's Q2 Earnings Call: Margins, Capex, and the FY27 Bridge
|
2mo |
|
+15
|
ER 27 Timeline
|
2mo |
|
+12
|
Texas ER work life?
|
2mo |
|
0
|
Deriving Fixed/Variable Costs with Limited Disclosure
|
2mo |
|
+9
|
IB SA -> ER
|
2mo |
|
+9
|
Ford's CEO and CFO sounded exactly the same on the Q4 call. That's weird, right?
|
2mo |
|
+4
|
Best ER firms?
|
2mo |
|
0
|
SIG 2026 Full-time ER
|
2mo |
|
+9
|
Let go from LO cross-asset seat. How to position next move?
|
2mo |
|
0
|
ESG Research Analyst > Investment Analyst in an ESG fund
|
2mo |
|
+1
|
ER (London) BB Comp 2026?
|
2mo |
|
+9
|
Bloomberg Intelligence vs Sell-Side Equity Research → Buyside Path?
|
2mo |
|
+16
|
Looking for help in choosing London Master’s degree
|
2mo |
|
+32
|
Q&A New Mentor | Senior Buyside Analyst – Equity Research, Healthcare Coverage & Breaking into the Buyside
|
2mo |
|
+4
|
Industry landscapes and themes
|
2mo |
|
0
|
Gilder Gagnon Howe
|
2mo |
|
+9
|
Analyzing Distribution Patterns: Form 4 Outflows and Foundry Cycles
|
2mo |
|
+9
|
are in-person channel checks for consumer companies useful
|
2mo |
|
+3
|
Timeline post case study
|
2mo |
|
+6
|
Good insurance industry ER primer / initiation?
|
2mo |
|
+44
|
Support Group for ER Associates Working IB Hours
|
2mo |
|
+9
|
Institutional Capital Allocation: Decoding the Macro Shift Through Regulatory Disclosures
|
2mo |
|
+9
|
Evaluating the Disconnect: Institutional Sentiment vs. C-Suite Capital Allocation in Discount Retail
|
3mo |
|
+15
|
What should I be reading?
|
3mo |
|
0
|
Where can I find good Stock Pitch Decks? (specifically for Biotech/Pharma)
|
3mo |
|
+6
|
sell-side analyst in US
|
3mo |
|
0
|
Help with Fixed Income Research Interview MS 2027 Summer
|
3mo |
|
+18
|
Aside from an easier earnings season, why leave sell side for a LO?
|
3mo |
|
+8
|
How deep does the rabbit hole go?
|
3mo |
|
+13
|
Why does any firm issue a hold rating?
|
3mo |
|
+9
|
Hi! Interview for Research Associate position
|
3mo |
|
+9
|
Appropriate discount rate for a taxable and nontaxable entity investing in the same project
|
3mo |
|
0
|
Still in consideration?
|
3mo |
|
0
|
BMO Consumer ER TO
|
3mo |
|
+26
|
Is equity research "easy" to get into compared to other fields.
|
3mo |
|
0
|
What Banks Are Going To Open ER Apps for SA 27?
|
3mo |
|
+11
|
How easy is it to switch sectors once you start your career
|
3mo |
|
+6
|
Citi ER SA 2027
|
3mo |
|
+5
|
Goldman ER 2027
|
3mo |
|
0
|
Anyone heard of cuts at JPM ER?
|
3mo |
|
0
|
JPM ER SA 2027
|
3mo |
|
0
|
Bofa ER 2027
|
3mo |
|
+11
|
ER interview with lead analyst
|
3mo |
|
+3
|
Hi all, i have a super day coming up for equity research at Morgan Stanley. What Technical and overall questions can i expect for this interview?
|
3mo |
|
+10
|
MS ER SA 2027 proccess?
|
3mo |
|
+13
|
ER boutiques in london
|
3mo |
|
+9
|
New Grad ER Associate -email from future boss about86/87.
|
3mo |
|
0
|
Morgan Stanley Equity Research 2027 (NYC)
|
3mo |
|
+8
|
Baird 27 SA
|
3mo |
|
+3
|
Jefferies TO ER Role
|
3mo |
|
+3
|
BofA ER SA 2027
|
3mo |
|
0
|
BofA superday
|
3mo |
|
0
|
Capital Markets Model Test
|
3mo |
|
0
|
Power / Energy Asset DCF Template?
|
3mo |
|
+6
|
DE Shaw Fundamental Research Internship Interview and Case Study
|
3mo |
|
+30
|
2025 ER Comp Thread
|
3mo |
|
0
|
UBS Equity Research SPD 2/20
|
3mo |
|
+10
|
UBS ER 2026
|
3mo |
|
0
|
Equity Research
|
3mo |
|
+10
|
What type of training is given to ER associates out of school versus lateral hires (untraditional backgrounds)
|
3mo |
or Want to Sign up with your social account?